The European Medicines Agency (EMA) plans to assess in the coming months whether it will approve the vaccine of Chinese manufacturer Sinovac in the EU. “We will assess the extent to which EU standards for efficacy, safety and quality are met,” the EMA said in Amsterdam on Tuesday. However, it did not give a date when a final decision could be expected.
Continue reading now
Get 30 days of free access to the Decision Brief to read these and more quality news every day.
Are you already a guest at the China.Table? Log in now